177 related articles for article (PubMed ID: 29389881)
1. Tyrosine Hydroxylase, Vesicular Monoamine Transporter and Dopamine Transporter mRNA Expression in Nigrostriatal Tissue of Rats with Pedunculopontine Neurotoxic Lesion.
Blanco-Lezcano L; Alberti-Amador E; Díaz-Hung ML; González-Fraguela ME; Estupiñán-Díaz B; Serrano-Sánchez T; Francis-Turner L; Jiménez-Martín J; Vega-Hurtado Y; Fernández-Jiménez I
Behav Sci (Basel); 2018 Feb; 8(2):. PubMed ID: 29389881
[TBL] [Abstract][Full Text] [Related]
2. Nurr1, Pitx3, and α7 nAChRs mRNA Expression in Nigral Tissue of Rats with Pedunculopontine Neurotoxic Lesion.
Blanco-Lezcano L; Alberti-Amador E; González-Fraguela ME; Larrea GZ; Pérez-Serrano RM; Jiménez-Luna NA; Serrano-Sánchez T; Francis-Turner L; Camejo-Rodriguez D; Vega-Hurtado Y
Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31547185
[No Abstract] [Full Text] [Related]
3. Effect of neurotoxic lesion of pedunculopontine nucleus in nigral and striatal redox balance and motor performance in rats.
Jimenez-Martin J; Blanco-Lezcano L; González-Fraguela ME; Díaz-Hung ML; Serrano-Sánchez T; Almenares JL; Francis-Turner L
Neuroscience; 2015 Mar; 289():300-14. PubMed ID: 25596320
[TBL] [Abstract][Full Text] [Related]
4. Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area.
Adelbrecht C; Agid Y; Raisman-Vozari R
Brain Res Mol Brain Res; 1996 Dec; 43(1-2):291-300. PubMed ID: 9037545
[TBL] [Abstract][Full Text] [Related]
5. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
[TBL] [Abstract][Full Text] [Related]
6. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.
Pienaar IS; van de Berg W
Exp Neurol; 2013 Oct; 248():213-23. PubMed ID: 23769975
[TBL] [Abstract][Full Text] [Related]
7. Motor dysfunction and alterations in glutathione concentration, cholinesterase activity, and BDNF expression in substantia nigra pars compacta in rats with pedunculopontine lesion.
Blanco-Lezcano L; Jimenez-Martin J; Díaz-Hung ML; Alberti-Amador E; Wong-Guerra M; González-Fraguela ME; Estupiñán-Díaz B; Serrano-Sánchez T; Francis-Turner L; Delgado-Ocaña S; Núñez-Figueredo Y; Vega-Hurtado Y; Fernández-Jiménez I
Neuroscience; 2017 Apr; 348():83-97. PubMed ID: 28212832
[TBL] [Abstract][Full Text] [Related]
8. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
[TBL] [Abstract][Full Text] [Related]
9. Motor Coordination Disorders Evaluated through the Grid Test and Changes in the Nigral
Lezcano LB; Alberti Amador E; González Fraguela ME; Zaldívar Lelo de Larrea G; Serrano RMP; Jiménez Luna NA; Camejo Rodríguez D; Serrano Sánchez T; Francis Turner L; Estupiñán Díaz B; Vega Hurtado Y; Fernández Jiménez I
Behav Sci (Basel); 2020 Oct; 10(10):. PubMed ID: 33066049
[TBL] [Abstract][Full Text] [Related]
10. Oestrogens prevent loss of dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) in substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice.
Jourdain S; Morissette M; Morin N; Di Paolo T
J Neuroendocrinol; 2005 Aug; 17(8):509-17. PubMed ID: 16011487
[TBL] [Abstract][Full Text] [Related]
11. Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson's Disease.
Elson JL; Kochaj R; Reynolds R; Pienaar IS
Neurotox Res; 2018 Jul; 34(1):16-31. PubMed ID: 29218504
[TBL] [Abstract][Full Text] [Related]
12. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat.
Breit S; Lessmann L; Benazzouz A; Schulz JB
Eur J Neurosci; 2005 Nov; 22(9):2283-94. PubMed ID: 16262666
[TBL] [Abstract][Full Text] [Related]
13. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M
J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855
[TBL] [Abstract][Full Text] [Related]
14. Regional metabolic changes in the pedunculopontine nucleus of unilateral 6-hydroxydopamine Parkinson's model rats.
Carlson JD; Pearlstein RD; Buchholz J; Iacono RP; Maeda G
Brain Res; 1999 May; 828(1-2):12-9. PubMed ID: 10320720
[TBL] [Abstract][Full Text] [Related]
15. [The effects of lesions in the compact part of the substantia nigra on glutamate and GABA release in the pedunculopontine nucleus].
Blanco-Lezcano L; Rocha-Arrieta LL; Alvarez-González L; Martínez-Martí L; Pavón-Fuentes N; González-Fraguela ME; Bauzá-Calderín Y; Coro-Grave de Peralta Y
Rev Neurol; 2005 Jan 1-15; 40(1):23-9. PubMed ID: 15696422
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
17. [Reduction of apomorphine-induced rotation in rats with additional destruction of the pedunculopontine nucleus contralateral to the unilateral nigrostriatal lesion].
Kannari K; Maeda T; Matsunaga M; Suda T
No To Shinkei; 1998 Jan; 50(1):33-7. PubMed ID: 9493196
[TBL] [Abstract][Full Text] [Related]
18. Protection against dopaminergic nigrostriatal cell death by excitatory input ablation.
Takada M; Matsumura M; Kojima J; Yamaji Y; Inase M; Tokuno H; Nambu A; Imai H
Eur J Neurosci; 2000 May; 12(5):1771-80. PubMed ID: 10792454
[TBL] [Abstract][Full Text] [Related]
19. An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease.
Pienaar IS; Harrison IF; Elson JL; Bury A; Woll P; Simon AK; Dexter DT
Brain Struct Funct; 2015 Jan; 220(1):479-500. PubMed ID: 24292256
[TBL] [Abstract][Full Text] [Related]
20. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
